Recurrence Rate Following Conservative Breast Surgery Versus Modified Radical Mastectomy in Triple Negative Patients | ||||
| Al-Azhar International Medical Journal | ||||
| Volume 2025, Issue 3, March 2025, Page 116-121 PDF (524.8 K) | ||||
| Document Type: Original Article | ||||
| DOI: https://doi.org/10.21608/aimj.2025.446473 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Mohamed Sobhy Teama1; Abdelhafez Abdelaziz Selim2; Rabie Shehata Hassan Gad Hariri3 | ||||
| 1Professor of General Surgery, Faculty of Medicine, Al-Azhar University, Cairo, Egypt; | ||||
| 2Associate Professor of General Surgery, Faculty of Medicine, Al-Azhar University, Cairo, Egypt | ||||
| 3MBBCh., Faculty of Medicine, Al-Azhar University, Cairo, Egypt | ||||
| Abstract | ||||
| Background: In terms of overall cancer incidence, breast cancer ranks second, and among women, it is by far the most frequent. Not only that, it kills more women than any other disease in the world. Its incidence and fatality rates vary among countries. In terms of overall cancer mortality, 16% is attributable to breast cancer, solidifying its status as a global health crisis. Aim and objectives: To find out how CBS compares to MRM in terms of oncologic and cosmetic outcomes for women whose breast cancer doesn't have any estrogen, progesterone, or human epidermal growth factor receptor 2 (referred to as "triple-negative breast cancer"). Patients and methods: A prospective retrospective study was conducted on 60-breast cancer patients attempt to the Surgery Department at Bab Al-Sharya University Hospital and Damnhour oncology center from December 2023 to October 2024. And another 200 breast cancer patients retrospectively, from 2021 to 2023. Results: The recurrence rate showed an insignificant difference between the conservative and MRM group in both retrospective and prospective studies. Conclusion: For patients with triple-negative breast cancer, oncologists recommend either BCS or MRM as a safe and effective therapy choice. BCS provides superior aesthetic outcomes. According to our short-term follow-up, the recurrence rate is not significantly different for patients who had BCS compared to those who received MRM. Clinical promotion for the treatment of early-stage breast cancer is warranted; however, due to the requirement of a delay in long-term follow-up. | ||||
| Keywords | ||||
| Breast Surgery; Radical Mastectomy; Triple Negative Patients | ||||
|
Statistics Article View: 1 |
||||
